Global Subcutaneous Drug Delivery Equipment Market Growth 2026-2032
The global Subcutaneous Drug Delivery Equipment market size is predicted to grow from US$ 35217 million in 2025 to US$ 58657 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.
Subcutaneous Drug Delivery Equipment refers to a class of drug delivery devices or systems that administer drugs into the subcutaneous tissue, with the core value of bypassing the skin's stratum corneum barrier to achieve efficient drug absorption. From an industry perspective, this field encompasses three major technological forms. The first is traditional needle-based devices such as auto-injectors and prefilled syringes. The second is on-body injectors, which are wearable devices that adhere to the skin and can be programmed to automatically complete subcutaneous delivery of large-volume or high-viscosity drugs. The third is implantable devices such as subcutaneous implants and implantable infusion ports. The subcutaneous tissue lies beneath the dermis and consists of loose connective tissue and adipose tissue, rich in capillaries and lymphatic vessels, allowing drugs to rapidly enter systemic circulation after injection while exhibiting low local proteolytic enzyme activity, making it particularly suitable for the delivery of large-molecule drugs. In recent years, with the explosive growth of biologics, subcutaneous drug delivery has transitioned from a complementary approach to intravenous infusion into the core infrastructure for biologic commercialization. This shift not only compresses the single administration time from tens of minutes for intravenous infusion to minutes, but also drives the migration of treatment settings from hospitals to homes, enabling patients or their caregivers to perform administration, thereby reshaping the competitive landscape of the global pharmaceutical industry.
Market Development Opportunities and Key Drivers
The mature application of recombinant human hyaluronidase has enabled single subcutaneous injection volume to surpass the traditional 1.5 mL limit, removing barriers for subcutaneous administration of biologics such as monoclonal antibodies and peptides. The rising global prevalence of chronic diseases is driving rigid demand for home-use drug delivery devices. In 2024, the U.S. Food and Drug Administration consecutively approved multiple subcutaneous tumor immunotherapy products, while China's National Medical Products Administration included subcutaneous drug delivery formulations in the expansion categories for generic drug consistency evaluation. Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to extend core product lifecycles through acquisitions and collaborations.
Market Challenges and Risks
As drug-device combination products, subcutaneous drug delivery equipment must satisfy dual regulatory review requirements for both pharmaceuticals and devices, and divergent interpretations of the primary mode of action across jurisdictions often lead to extended review cycles. The European Medical Device Regulation has elevated auto-injectors to Class III status while notified body certification capacity remains constrained. Wearable injectors carry high costs, making widespread adoption difficult in self-pay dominant markets, and U.S. payers commonly require prior authorization for biologics with high annual costs. Critical components remain concentrated among a limited number of suppliers, making supply chain geopolitical risks a concern.
Downstream Demand Trends
Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to counter biosimilar competition through acquisitions and licensing. In 2025, Enable Injections' enFuse system received regulatory approvals from both Brazil and the United Kingdom, signaling that wearable large-volume subcutaneous injection technology is gaining global regulatory acceptance. Chronic disease patients favor wearable injectors that can be worn for hours to automatically complete drug delivery, while oncology patients value the reduction of treatment time from half a day to minutes. The United Kingdom government has initiated a multi-billion pound program to promote hybrid closed-loop insulin systems, reflecting public payers' confidence in home-based subcutaneous drug delivery models.
Regional Trends
North America continues to dominate innovation and early commercialization, leveraging its dense biopharmaceutical clusters and mature drug-device combination review experience, with the U.S. Food and Drug Administration approving multiple subcutaneous tumor immunotherapy products in 2024. Europe emphasizes real-world evidence and health technology assessment, with Germany's Federal Joint Committee imposing stricter requirements for additional benefit assessment of novel drug-device combination products, positioning the region as a critical proving ground for clinical and economic value. China and the broader Asia-Pacific region are transitioning from generic following to integrated innovation, with large chronic disease patient populations and rapidly iterating manufacturing capabilities providing unique engineering advantages for local companies.
LP Information, Inc. (LPI) ' newest research report, the ?Subcutaneous Drug Delivery Equipment Industry Forecast? looks at past sales and reviews total world Subcutaneous Drug Delivery Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected Subcutaneous Drug Delivery Equipment sales for 2026 through 2032. With Subcutaneous Drug Delivery Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Drug Delivery Equipment industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Drug Delivery Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Drug Delivery Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Subcutaneous Drug Delivery Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Drug Delivery Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Drug Delivery Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Drug Delivery Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Subcutaneous Drug Delivery Equipment refers to a class of drug delivery devices or systems that administer drugs into the subcutaneous tissue, with the core value of bypassing the skin's stratum corneum barrier to achieve efficient drug absorption. From an industry perspective, this field encompasses three major technological forms. The first is traditional needle-based devices such as auto-injectors and prefilled syringes. The second is on-body injectors, which are wearable devices that adhere to the skin and can be programmed to automatically complete subcutaneous delivery of large-volume or high-viscosity drugs. The third is implantable devices such as subcutaneous implants and implantable infusion ports. The subcutaneous tissue lies beneath the dermis and consists of loose connective tissue and adipose tissue, rich in capillaries and lymphatic vessels, allowing drugs to rapidly enter systemic circulation after injection while exhibiting low local proteolytic enzyme activity, making it particularly suitable for the delivery of large-molecule drugs. In recent years, with the explosive growth of biologics, subcutaneous drug delivery has transitioned from a complementary approach to intravenous infusion into the core infrastructure for biologic commercialization. This shift not only compresses the single administration time from tens of minutes for intravenous infusion to minutes, but also drives the migration of treatment settings from hospitals to homes, enabling patients or their caregivers to perform administration, thereby reshaping the competitive landscape of the global pharmaceutical industry.
Market Development Opportunities and Key Drivers
The mature application of recombinant human hyaluronidase has enabled single subcutaneous injection volume to surpass the traditional 1.5 mL limit, removing barriers for subcutaneous administration of biologics such as monoclonal antibodies and peptides. The rising global prevalence of chronic diseases is driving rigid demand for home-use drug delivery devices. In 2024, the U.S. Food and Drug Administration consecutively approved multiple subcutaneous tumor immunotherapy products, while China's National Medical Products Administration included subcutaneous drug delivery formulations in the expansion categories for generic drug consistency evaluation. Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to extend core product lifecycles through acquisitions and collaborations.
Market Challenges and Risks
As drug-device combination products, subcutaneous drug delivery equipment must satisfy dual regulatory review requirements for both pharmaceuticals and devices, and divergent interpretations of the primary mode of action across jurisdictions often lead to extended review cycles. The European Medical Device Regulation has elevated auto-injectors to Class III status while notified body certification capacity remains constrained. Wearable injectors carry high costs, making widespread adoption difficult in self-pay dominant markets, and U.S. payers commonly require prior authorization for biologics with high annual costs. Critical components remain concentrated among a limited number of suppliers, making supply chain geopolitical risks a concern.
Downstream Demand Trends
Large pharmaceutical companies are treating subcutaneous drug delivery platforms as strategic assets to counter biosimilar competition through acquisitions and licensing. In 2025, Enable Injections' enFuse system received regulatory approvals from both Brazil and the United Kingdom, signaling that wearable large-volume subcutaneous injection technology is gaining global regulatory acceptance. Chronic disease patients favor wearable injectors that can be worn for hours to automatically complete drug delivery, while oncology patients value the reduction of treatment time from half a day to minutes. The United Kingdom government has initiated a multi-billion pound program to promote hybrid closed-loop insulin systems, reflecting public payers' confidence in home-based subcutaneous drug delivery models.
Regional Trends
North America continues to dominate innovation and early commercialization, leveraging its dense biopharmaceutical clusters and mature drug-device combination review experience, with the U.S. Food and Drug Administration approving multiple subcutaneous tumor immunotherapy products in 2024. Europe emphasizes real-world evidence and health technology assessment, with Germany's Federal Joint Committee imposing stricter requirements for additional benefit assessment of novel drug-device combination products, positioning the region as a critical proving ground for clinical and economic value. China and the broader Asia-Pacific region are transitioning from generic following to integrated innovation, with large chronic disease patient populations and rapidly iterating manufacturing capabilities providing unique engineering advantages for local companies.
LP Information, Inc. (LPI) ' newest research report, the ?Subcutaneous Drug Delivery Equipment Industry Forecast? looks at past sales and reviews total world Subcutaneous Drug Delivery Equipment sales in 2025, providing a comprehensive analysis by region and market sector of projected Subcutaneous Drug Delivery Equipment sales for 2026 through 2032. With Subcutaneous Drug Delivery Equipment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Subcutaneous Drug Delivery Equipment industry.
This Insight Report provides a comprehensive analysis of the global Subcutaneous Drug Delivery Equipment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Subcutaneous Drug Delivery Equipment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Subcutaneous Drug Delivery Equipment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Subcutaneous Drug Delivery Equipment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Subcutaneous Drug Delivery Equipment.
This report presents a comprehensive overview, market shares, and growth opportunities of Subcutaneous Drug Delivery Equipment market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Syringe
- Injection Pen
- Implantable Device
- Manual Injection Device
- Spring Driven Device
- Motor Driven Device
- Gas-Powered Device
- Small Molecule Device
- Peptide and Protein Device
- Nucleic Acid Device
- Disposable Device
- Reusable Device
- Disease Treatment
- Vaccination
- Aesthetics and Cosmetics
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Becton Dickinson
- Ypsomed
- SHL Medical
- West Pharmaceutical Services
- Gerresheimer
- Owen Mumford
- Novo Nordisk
- Nemera
- Tandem Diabetes Care
- Enable Injections
- Stevanato Group
- MicroPort
- Weigao Group
- What is the 10-year outlook for the global Subcutaneous Drug Delivery Equipment market?
- What factors are driving Subcutaneous Drug Delivery Equipment market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doSubcutaneous Drug Delivery Equipment market opportunities vary by end market size?
- How does Subcutaneous Drug Delivery Equipment break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Subcutaneous Drug Delivery Equipment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Subcutaneous Drug Delivery Equipment by Country/Region, 2021, 2025 & 2032
2.2 Subcutaneous Drug Delivery Equipment Segment by Type
2.2.1 Syringe
2.2.2 Injection Pen
2.2.3 Implantable Device
2.2.4 Subcutaneous Drug Delivery Equipment Sales by Type
2.2.4.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
2.2.4.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Type (2021-2026)
2.3 Subcutaneous Drug Delivery Equipment Segment by Delivery Mechanism
2.3.1 Manual Injection Device
2.3.2 Spring Driven Device
2.3.3 Motor Driven Device
2.3.4 Gas-Powered Device
2.3.5 Subcutaneous Drug Delivery Equipment Sales by Delivery Mechanism
2.3.5.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Delivery Mechanism (2021-2026)
2.3.5.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Delivery Mechanism (2021-2026)
2.3.5.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Delivery Mechanism (2021-2026)
2.4 Subcutaneous Drug Delivery Equipment Segment by Drug Type
2.4.1 Small Molecule Device
2.4.2 Peptide and Protein Device
2.4.3 Nucleic Acid Device
2.4.4 Subcutaneous Drug Delivery Equipment Sales by Drug Type
2.4.4.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Drug Type (2021-2026)
2.4.4.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Drug Type (2021-2026)
2.4.4.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Drug Type (2021-2026)
2.5 Subcutaneous Drug Delivery Equipment Segment by Reusability
2.5.1 Disposable Device
2.5.2 Reusable Device
2.5.3 Subcutaneous Drug Delivery Equipment Sales by Reusability
2.5.3.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Reusability (2021-2026)
2.5.3.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Reusability (2021-2026)
2.5.3.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Reusability (2021-2026)
2.6 Subcutaneous Drug Delivery Equipment Segment by Application
2.6.1 Disease Treatment
2.6.2 Vaccination
2.6.3 Aesthetics and Cosmetics
2.6.4 Subcutaneous Drug Delivery Equipment Sales by Application
2.6.4.1 Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2021-2026)
2.6.4.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Subcutaneous Drug Delivery Equipment Breakdown Data by Company
3.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Company (2021-2026)
3.1.2 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company (2021-2026)
3.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Company (2021-2026)
3.2.1 Global Subcutaneous Drug Delivery Equipment Revenue by Company (2021-2026)
3.2.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company (2021-2026)
3.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Company
3.4 Key Manufacturers Subcutaneous Drug Delivery Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Drug Delivery Equipment Product Location Distribution
3.4.2 Players Subcutaneous Drug Delivery Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY GEOGRAPHIC REGION
4.1 World Historic Subcutaneous Drug Delivery Equipment Market Size by Geographic Region (2021-2026)
4.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Subcutaneous Drug Delivery Equipment Market Size by Country/Region (2021-2026)
4.2.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Subcutaneous Drug Delivery Equipment Sales Growth
4.4 APAC Subcutaneous Drug Delivery Equipment Sales Growth
4.5 Europe Subcutaneous Drug Delivery Equipment Sales Growth
4.6 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Growth
5 AMERICAS
5.1 Americas Subcutaneous Drug Delivery Equipment Sales by Country
5.1.1 Americas Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026)
5.1.2 Americas Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026)
5.2 Americas Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
5.3 Americas Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Drug Delivery Equipment Sales by Region
6.1.1 APAC Subcutaneous Drug Delivery Equipment Sales by Region (2021-2026)
6.1.2 APAC Subcutaneous Drug Delivery Equipment Revenue by Region (2021-2026)
6.2 APAC Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
6.3 APAC Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Subcutaneous Drug Delivery Equipment by Country
7.1.1 Europe Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026)
7.1.2 Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026)
7.2 Europe Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
7.3 Europe Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Drug Delivery Equipment by Country
8.1.1 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026)
8.2 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
8.3 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Equipment
10.3 Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
10.4 Industry Chain Structure of Subcutaneous Drug Delivery Equipment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Drug Delivery Equipment Distributors
11.3 Subcutaneous Drug Delivery Equipment Customer
12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY GEOGRAPHIC REGION
12.1 Global Subcutaneous Drug Delivery Equipment Market Size Forecast by Region
12.1.1 Global Subcutaneous Drug Delivery Equipment Forecast by Region (2027-2032)
12.1.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Subcutaneous Drug Delivery Equipment Forecast by Type (2027-2032)
12.7 Global Subcutaneous Drug Delivery Equipment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Information
13.1.2 Becton Dickinson Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.1.3 Becton Dickinson Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Becton Dickinson Main Business Overview
13.1.5 Becton Dickinson Latest Developments
13.2 Ypsomed
13.2.1 Ypsomed Company Information
13.2.2 Ypsomed Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.2.3 Ypsomed Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ypsomed Main Business Overview
13.2.5 Ypsomed Latest Developments
13.3 SHL Medical
13.3.1 SHL Medical Company Information
13.3.2 SHL Medical Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.3.3 SHL Medical Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 SHL Medical Main Business Overview
13.3.5 SHL Medical Latest Developments
13.4 West Pharmaceutical Services
13.4.1 West Pharmaceutical Services Company Information
13.4.2 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.4.3 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 West Pharmaceutical Services Main Business Overview
13.4.5 West Pharmaceutical Services Latest Developments
13.5 Gerresheimer
13.5.1 Gerresheimer Company Information
13.5.2 Gerresheimer Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.5.3 Gerresheimer Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Gerresheimer Main Business Overview
13.5.5 Gerresheimer Latest Developments
13.6 Owen Mumford
13.6.1 Owen Mumford Company Information
13.6.2 Owen Mumford Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.6.3 Owen Mumford Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Owen Mumford Main Business Overview
13.6.5 Owen Mumford Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.7.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Nemera
13.8.1 Nemera Company Information
13.8.2 Nemera Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.8.3 Nemera Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Nemera Main Business Overview
13.8.5 Nemera Latest Developments
13.9 Tandem Diabetes Care
13.9.1 Tandem Diabetes Care Company Information
13.9.2 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.9.3 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Tandem Diabetes Care Main Business Overview
13.9.5 Tandem Diabetes Care Latest Developments
13.10 Enable Injections
13.10.1 Enable Injections Company Information
13.10.2 Enable Injections Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.10.3 Enable Injections Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Enable Injections Main Business Overview
13.10.5 Enable Injections Latest Developments
13.11 Stevanato Group
13.11.1 Stevanato Group Company Information
13.11.2 Stevanato Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.11.3 Stevanato Group Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Stevanato Group Main Business Overview
13.11.5 Stevanato Group Latest Developments
13.12 MicroPort
13.12.1 MicroPort Company Information
13.12.2 MicroPort Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.12.3 MicroPort Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 MicroPort Main Business Overview
13.12.5 MicroPort Latest Developments
13.13 Weigao Group
13.13.1 Weigao Group Company Information
13.13.2 Weigao Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.13.3 Weigao Group Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Weigao Group Main Business Overview
13.13.5 Weigao Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Subcutaneous Drug Delivery Equipment by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Subcutaneous Drug Delivery Equipment by Country/Region, 2021, 2025 & 2032
2.2 Subcutaneous Drug Delivery Equipment Segment by Type
2.2.1 Syringe
2.2.2 Injection Pen
2.2.3 Implantable Device
2.2.4 Subcutaneous Drug Delivery Equipment Sales by Type
2.2.4.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
2.2.4.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Type (2021-2026)
2.3 Subcutaneous Drug Delivery Equipment Segment by Delivery Mechanism
2.3.1 Manual Injection Device
2.3.2 Spring Driven Device
2.3.3 Motor Driven Device
2.3.4 Gas-Powered Device
2.3.5 Subcutaneous Drug Delivery Equipment Sales by Delivery Mechanism
2.3.5.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Delivery Mechanism (2021-2026)
2.3.5.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Delivery Mechanism (2021-2026)
2.3.5.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Delivery Mechanism (2021-2026)
2.4 Subcutaneous Drug Delivery Equipment Segment by Drug Type
2.4.1 Small Molecule Device
2.4.2 Peptide and Protein Device
2.4.3 Nucleic Acid Device
2.4.4 Subcutaneous Drug Delivery Equipment Sales by Drug Type
2.4.4.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Drug Type (2021-2026)
2.4.4.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Drug Type (2021-2026)
2.4.4.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Drug Type (2021-2026)
2.5 Subcutaneous Drug Delivery Equipment Segment by Reusability
2.5.1 Disposable Device
2.5.2 Reusable Device
2.5.3 Subcutaneous Drug Delivery Equipment Sales by Reusability
2.5.3.1 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Reusability (2021-2026)
2.5.3.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Reusability (2021-2026)
2.5.3.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Reusability (2021-2026)
2.6 Subcutaneous Drug Delivery Equipment Segment by Application
2.6.1 Disease Treatment
2.6.2 Vaccination
2.6.3 Aesthetics and Cosmetics
2.6.4 Subcutaneous Drug Delivery Equipment Sales by Application
2.6.4.1 Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2021-2026)
2.6.4.2 Global Subcutaneous Drug Delivery Equipment Revenue and Market Share by Application (2021-2026)
2.6.4.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Subcutaneous Drug Delivery Equipment Breakdown Data by Company
3.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Company (2021-2026)
3.1.2 Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company (2021-2026)
3.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Company (2021-2026)
3.2.1 Global Subcutaneous Drug Delivery Equipment Revenue by Company (2021-2026)
3.2.2 Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company (2021-2026)
3.3 Global Subcutaneous Drug Delivery Equipment Sale Price by Company
3.4 Key Manufacturers Subcutaneous Drug Delivery Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Subcutaneous Drug Delivery Equipment Product Location Distribution
3.4.2 Players Subcutaneous Drug Delivery Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY GEOGRAPHIC REGION
4.1 World Historic Subcutaneous Drug Delivery Equipment Market Size by Geographic Region (2021-2026)
4.1.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Subcutaneous Drug Delivery Equipment Market Size by Country/Region (2021-2026)
4.2.1 Global Subcutaneous Drug Delivery Equipment Annual Sales by Country/Region (2021-2026)
4.2.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue by Country/Region (2021-2026)
4.3 Americas Subcutaneous Drug Delivery Equipment Sales Growth
4.4 APAC Subcutaneous Drug Delivery Equipment Sales Growth
4.5 Europe Subcutaneous Drug Delivery Equipment Sales Growth
4.6 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Growth
5 AMERICAS
5.1 Americas Subcutaneous Drug Delivery Equipment Sales by Country
5.1.1 Americas Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026)
5.1.2 Americas Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026)
5.2 Americas Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
5.3 Americas Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Subcutaneous Drug Delivery Equipment Sales by Region
6.1.1 APAC Subcutaneous Drug Delivery Equipment Sales by Region (2021-2026)
6.1.2 APAC Subcutaneous Drug Delivery Equipment Revenue by Region (2021-2026)
6.2 APAC Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
6.3 APAC Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Subcutaneous Drug Delivery Equipment by Country
7.1.1 Europe Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026)
7.1.2 Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026)
7.2 Europe Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
7.3 Europe Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Subcutaneous Drug Delivery Equipment by Country
8.1.1 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026)
8.1.2 Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026)
8.2 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026)
8.3 Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Equipment
10.3 Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
10.4 Industry Chain Structure of Subcutaneous Drug Delivery Equipment
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Subcutaneous Drug Delivery Equipment Distributors
11.3 Subcutaneous Drug Delivery Equipment Customer
12 WORLD FORECAST REVIEW FOR SUBCUTANEOUS DRUG DELIVERY EQUIPMENT BY GEOGRAPHIC REGION
12.1 Global Subcutaneous Drug Delivery Equipment Market Size Forecast by Region
12.1.1 Global Subcutaneous Drug Delivery Equipment Forecast by Region (2027-2032)
12.1.2 Global Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Subcutaneous Drug Delivery Equipment Forecast by Type (2027-2032)
12.7 Global Subcutaneous Drug Delivery Equipment Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Becton Dickinson
13.1.1 Becton Dickinson Company Information
13.1.2 Becton Dickinson Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.1.3 Becton Dickinson Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Becton Dickinson Main Business Overview
13.1.5 Becton Dickinson Latest Developments
13.2 Ypsomed
13.2.1 Ypsomed Company Information
13.2.2 Ypsomed Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.2.3 Ypsomed Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Ypsomed Main Business Overview
13.2.5 Ypsomed Latest Developments
13.3 SHL Medical
13.3.1 SHL Medical Company Information
13.3.2 SHL Medical Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.3.3 SHL Medical Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 SHL Medical Main Business Overview
13.3.5 SHL Medical Latest Developments
13.4 West Pharmaceutical Services
13.4.1 West Pharmaceutical Services Company Information
13.4.2 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.4.3 West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 West Pharmaceutical Services Main Business Overview
13.4.5 West Pharmaceutical Services Latest Developments
13.5 Gerresheimer
13.5.1 Gerresheimer Company Information
13.5.2 Gerresheimer Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.5.3 Gerresheimer Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Gerresheimer Main Business Overview
13.5.5 Gerresheimer Latest Developments
13.6 Owen Mumford
13.6.1 Owen Mumford Company Information
13.6.2 Owen Mumford Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.6.3 Owen Mumford Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Owen Mumford Main Business Overview
13.6.5 Owen Mumford Latest Developments
13.7 Novo Nordisk
13.7.1 Novo Nordisk Company Information
13.7.2 Novo Nordisk Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.7.3 Novo Nordisk Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Novo Nordisk Main Business Overview
13.7.5 Novo Nordisk Latest Developments
13.8 Nemera
13.8.1 Nemera Company Information
13.8.2 Nemera Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.8.3 Nemera Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Nemera Main Business Overview
13.8.5 Nemera Latest Developments
13.9 Tandem Diabetes Care
13.9.1 Tandem Diabetes Care Company Information
13.9.2 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.9.3 Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Tandem Diabetes Care Main Business Overview
13.9.5 Tandem Diabetes Care Latest Developments
13.10 Enable Injections
13.10.1 Enable Injections Company Information
13.10.2 Enable Injections Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.10.3 Enable Injections Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Enable Injections Main Business Overview
13.10.5 Enable Injections Latest Developments
13.11 Stevanato Group
13.11.1 Stevanato Group Company Information
13.11.2 Stevanato Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.11.3 Stevanato Group Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Stevanato Group Main Business Overview
13.11.5 Stevanato Group Latest Developments
13.12 MicroPort
13.12.1 MicroPort Company Information
13.12.2 MicroPort Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.12.3 MicroPort Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 MicroPort Main Business Overview
13.12.5 MicroPort Latest Developments
13.13 Weigao Group
13.13.1 Weigao Group Company Information
13.13.2 Weigao Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
13.13.3 Weigao Group Subcutaneous Drug Delivery Equipment Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Weigao Group Main Business Overview
13.13.5 Weigao Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Subcutaneous Drug Delivery Equipment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Subcutaneous Drug Delivery Equipment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Syringe
Table 4. Major Players of Injection Pen
Table 5. Major Players of Implantable Device
Table 6. Global Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 7. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Table 8. Global Subcutaneous Drug Delivery Equipment Revenue by Type (2021-2026) & ($ million)
Table 9. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2021-2026)
Table 10. Global Subcutaneous Drug Delivery Equipment Sale Price by Type (2021-2026) & (USD/Unit)
Table 11. Major Players of Manual Injection Device
Table 12. Major Players of Spring Driven Device
Table 13. Major Players of Motor Driven Device
Table 14. Major Players of Gas-Powered Device
Table 15. Global Subcutaneous Drug Delivery Equipment Sales by Delivery Mechanism (2021-2026) & (Units)
Table 16. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Delivery Mechanism (2021-2026)
Table 17. Global Subcutaneous Drug Delivery Equipment Revenue by Delivery Mechanism (2021-2026) & ($ million)
Table 18. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Delivery Mechanism (2021-2026)
Table 19. Global Subcutaneous Drug Delivery Equipment Sale Price by Delivery Mechanism (2021-2026) & (USD/Unit)
Table 20. Major Players of Small Molecule Device
Table 21. Major Players of Peptide and Protein Device
Table 22. Major Players of Nucleic Acid Device
Table 23. Global Subcutaneous Drug Delivery Equipment Sales by Drug Type (2021-2026) & (Units)
Table 24. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Drug Type (2021-2026)
Table 25. Global Subcutaneous Drug Delivery Equipment Revenue by Drug Type (2021-2026) & ($ million)
Table 26. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Drug Type (2021-2026)
Table 27. Global Subcutaneous Drug Delivery Equipment Sale Price by Drug Type (2021-2026) & (USD/Unit)
Table 28. Major Players of Disposable Device
Table 29. Major Players of Reusable Device
Table 30. Global Subcutaneous Drug Delivery Equipment Sales by Reusability (2021-2026) & (Units)
Table 31. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Reusability (2021-2026)
Table 32. Global Subcutaneous Drug Delivery Equipment Revenue by Reusability (2021-2026) & ($ million)
Table 33. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Reusability (2021-2026)
Table 34. Global Subcutaneous Drug Delivery Equipment Sale Price by Reusability (2021-2026) & (USD/Unit)
Table 35. Global Subcutaneous Drug Delivery Equipment Sale by Application (2021-2026) & (Units)
Table 36. Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2021-2026)
Table 37. Global Subcutaneous Drug Delivery Equipment Revenue by Application (2021-2026) & ($ million)
Table 38. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2021-2026)
Table 39. Global Subcutaneous Drug Delivery Equipment Sale Price by Application (2021-2026) & (USD/Unit)
Table 40. Global Subcutaneous Drug Delivery Equipment Sales by Company (2021-2026) & (Units)
Table 41. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company (2021-2026)
Table 42. Global Subcutaneous Drug Delivery Equipment Revenue by Company (2021-2026) & ($ millions)
Table 43. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company (2021-2026)
Table 44. Global Subcutaneous Drug Delivery Equipment Sale Price by Company (2021-2026) & (USD/Unit)
Table 45. Key Manufacturers Subcutaneous Drug Delivery Equipment Producing Area Distribution and Sales Area
Table 46. Players Subcutaneous Drug Delivery Equipment Products Offered
Table 47. Subcutaneous Drug Delivery Equipment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 48. New Products and Potential Entrants
Table 49. Market M&A Activity & Strategy
Table 50. Global Subcutaneous Drug Delivery Equipment Sales by Geographic Region (2021-2026) & (Units)
Table 51. Global Subcutaneous Drug Delivery Equipment Sales Market Share Geographic Region (2021-2026)
Table 52. Global Subcutaneous Drug Delivery Equipment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 53. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Geographic Region (2021-2026)
Table 54. Global Subcutaneous Drug Delivery Equipment Sales by Country/Region (2021-2026) & (Units)
Table 55. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2021-2026)
Table 56. Global Subcutaneous Drug Delivery Equipment Revenue by Country/Region (2021-2026) & ($ millions)
Table 57. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Country/Region (2021-2026)
Table 58. Americas Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026) & (Units)
Table 59. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2021-2026)
Table 60. Americas Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026) & ($ millions)
Table 61. Americas Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 62. Americas Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 63. APAC Subcutaneous Drug Delivery Equipment Sales by Region (2021-2026) & (Units)
Table 64. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2021-2026)
Table 65. APAC Subcutaneous Drug Delivery Equipment Revenue by Region (2021-2026) & ($ millions)
Table 66. APAC Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 67. APAC Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 68. Europe Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026) & (Units)
Table 69. Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026) & ($ millions)
Table 70. Europe Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 71. Europe Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 72. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026) & (Units)
Table 73. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2021-2026)
Table 74. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 75. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 76. Key Market Drivers & Growth Opportunities of Subcutaneous Drug Delivery Equipment
Table 77. Key Market Challenges & Risks of Subcutaneous Drug Delivery Equipment
Table 78. Key Industry Trends of Subcutaneous Drug Delivery Equipment
Table 79. Subcutaneous Drug Delivery Equipment Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Subcutaneous Drug Delivery Equipment Distributors List
Table 82. Subcutaneous Drug Delivery Equipment Customer List
Table 83. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 84. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Americas Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 86. Americas Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. APAC Subcutaneous Drug Delivery Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 88. APAC Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Europe Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 90. Europe Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 92. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Type (2027-2032) & (Units)
Table 94. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 95. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Application (2027-2032) & (Units)
Table 96. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 97. Becton Dickinson Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 98. Becton Dickinson Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 99. Becton Dickinson Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 100. Becton Dickinson Main Business
Table 101. Becton Dickinson Latest Developments
Table 102. Ypsomed Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 103. Ypsomed Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 104. Ypsomed Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 105. Ypsomed Main Business
Table 106. Ypsomed Latest Developments
Table 107. SHL Medical Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 108. SHL Medical Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 109. SHL Medical Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 110. SHL Medical Main Business
Table 111. SHL Medical Latest Developments
Table 112. West Pharmaceutical Services Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 113. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 114. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 115. West Pharmaceutical Services Main Business
Table 116. West Pharmaceutical Services Latest Developments
Table 117. Gerresheimer Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 118. Gerresheimer Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 119. Gerresheimer Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 120. Gerresheimer Main Business
Table 121. Gerresheimer Latest Developments
Table 122. Owen Mumford Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 123. Owen Mumford Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 124. Owen Mumford Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 125. Owen Mumford Main Business
Table 126. Owen Mumford Latest Developments
Table 127. Novo Nordisk Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 128. Novo Nordisk Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 129. Novo Nordisk Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 130. Novo Nordisk Main Business
Table 131. Novo Nordisk Latest Developments
Table 132. Nemera Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 133. Nemera Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 134. Nemera Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 135. Nemera Main Business
Table 136. Nemera Latest Developments
Table 137. Tandem Diabetes Care Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 138. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 139. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 140. Tandem Diabetes Care Main Business
Table 141. Tandem Diabetes Care Latest Developments
Table 142. Enable Injections Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 143. Enable Injections Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 144. Enable Injections Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 145. Enable Injections Main Business
Table 146. Enable Injections Latest Developments
Table 147. Stevanato Group Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 148. Stevanato Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 149. Stevanato Group Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 150. Stevanato Group Main Business
Table 151. Stevanato Group Latest Developments
Table 152. MicroPort Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 153. MicroPort Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 154. MicroPort Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 155. MicroPort Main Business
Table 156. MicroPort Latest Developments
Table 157. Weigao Group Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 158. Weigao Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 159. Weigao Group Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 160. Weigao Group Main Business
Table 161. Weigao Group Latest Developments
Table 1. Subcutaneous Drug Delivery Equipment Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Subcutaneous Drug Delivery Equipment Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Syringe
Table 4. Major Players of Injection Pen
Table 5. Major Players of Implantable Device
Table 6. Global Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 7. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Table 8. Global Subcutaneous Drug Delivery Equipment Revenue by Type (2021-2026) & ($ million)
Table 9. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2021-2026)
Table 10. Global Subcutaneous Drug Delivery Equipment Sale Price by Type (2021-2026) & (USD/Unit)
Table 11. Major Players of Manual Injection Device
Table 12. Major Players of Spring Driven Device
Table 13. Major Players of Motor Driven Device
Table 14. Major Players of Gas-Powered Device
Table 15. Global Subcutaneous Drug Delivery Equipment Sales by Delivery Mechanism (2021-2026) & (Units)
Table 16. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Delivery Mechanism (2021-2026)
Table 17. Global Subcutaneous Drug Delivery Equipment Revenue by Delivery Mechanism (2021-2026) & ($ million)
Table 18. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Delivery Mechanism (2021-2026)
Table 19. Global Subcutaneous Drug Delivery Equipment Sale Price by Delivery Mechanism (2021-2026) & (USD/Unit)
Table 20. Major Players of Small Molecule Device
Table 21. Major Players of Peptide and Protein Device
Table 22. Major Players of Nucleic Acid Device
Table 23. Global Subcutaneous Drug Delivery Equipment Sales by Drug Type (2021-2026) & (Units)
Table 24. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Drug Type (2021-2026)
Table 25. Global Subcutaneous Drug Delivery Equipment Revenue by Drug Type (2021-2026) & ($ million)
Table 26. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Drug Type (2021-2026)
Table 27. Global Subcutaneous Drug Delivery Equipment Sale Price by Drug Type (2021-2026) & (USD/Unit)
Table 28. Major Players of Disposable Device
Table 29. Major Players of Reusable Device
Table 30. Global Subcutaneous Drug Delivery Equipment Sales by Reusability (2021-2026) & (Units)
Table 31. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Reusability (2021-2026)
Table 32. Global Subcutaneous Drug Delivery Equipment Revenue by Reusability (2021-2026) & ($ million)
Table 33. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Reusability (2021-2026)
Table 34. Global Subcutaneous Drug Delivery Equipment Sale Price by Reusability (2021-2026) & (USD/Unit)
Table 35. Global Subcutaneous Drug Delivery Equipment Sale by Application (2021-2026) & (Units)
Table 36. Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2021-2026)
Table 37. Global Subcutaneous Drug Delivery Equipment Revenue by Application (2021-2026) & ($ million)
Table 38. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application (2021-2026)
Table 39. Global Subcutaneous Drug Delivery Equipment Sale Price by Application (2021-2026) & (USD/Unit)
Table 40. Global Subcutaneous Drug Delivery Equipment Sales by Company (2021-2026) & (Units)
Table 41. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company (2021-2026)
Table 42. Global Subcutaneous Drug Delivery Equipment Revenue by Company (2021-2026) & ($ millions)
Table 43. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company (2021-2026)
Table 44. Global Subcutaneous Drug Delivery Equipment Sale Price by Company (2021-2026) & (USD/Unit)
Table 45. Key Manufacturers Subcutaneous Drug Delivery Equipment Producing Area Distribution and Sales Area
Table 46. Players Subcutaneous Drug Delivery Equipment Products Offered
Table 47. Subcutaneous Drug Delivery Equipment Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 48. New Products and Potential Entrants
Table 49. Market M&A Activity & Strategy
Table 50. Global Subcutaneous Drug Delivery Equipment Sales by Geographic Region (2021-2026) & (Units)
Table 51. Global Subcutaneous Drug Delivery Equipment Sales Market Share Geographic Region (2021-2026)
Table 52. Global Subcutaneous Drug Delivery Equipment Revenue by Geographic Region (2021-2026) & ($ millions)
Table 53. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Geographic Region (2021-2026)
Table 54. Global Subcutaneous Drug Delivery Equipment Sales by Country/Region (2021-2026) & (Units)
Table 55. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2021-2026)
Table 56. Global Subcutaneous Drug Delivery Equipment Revenue by Country/Region (2021-2026) & ($ millions)
Table 57. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Country/Region (2021-2026)
Table 58. Americas Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026) & (Units)
Table 59. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2021-2026)
Table 60. Americas Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026) & ($ millions)
Table 61. Americas Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 62. Americas Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 63. APAC Subcutaneous Drug Delivery Equipment Sales by Region (2021-2026) & (Units)
Table 64. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Region (2021-2026)
Table 65. APAC Subcutaneous Drug Delivery Equipment Revenue by Region (2021-2026) & ($ millions)
Table 66. APAC Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 67. APAC Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 68. Europe Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026) & (Units)
Table 69. Europe Subcutaneous Drug Delivery Equipment Revenue by Country (2021-2026) & ($ millions)
Table 70. Europe Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 71. Europe Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 72. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Country (2021-2026) & (Units)
Table 73. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2021-2026)
Table 74. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Type (2021-2026) & (Units)
Table 75. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales by Application (2021-2026) & (Units)
Table 76. Key Market Drivers & Growth Opportunities of Subcutaneous Drug Delivery Equipment
Table 77. Key Market Challenges & Risks of Subcutaneous Drug Delivery Equipment
Table 78. Key Industry Trends of Subcutaneous Drug Delivery Equipment
Table 79. Subcutaneous Drug Delivery Equipment Raw Material
Table 80. Key Suppliers of Raw Materials
Table 81. Subcutaneous Drug Delivery Equipment Distributors List
Table 82. Subcutaneous Drug Delivery Equipment Customer List
Table 83. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 84. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Region (2027-2032) & ($ millions)
Table 85. Americas Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 86. Americas Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 87. APAC Subcutaneous Drug Delivery Equipment Sales Forecast by Region (2027-2032) & (Units)
Table 88. APAC Subcutaneous Drug Delivery Equipment Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 89. Europe Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 90. Europe Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 91. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Forecast by Country (2027-2032) & (Units)
Table 92. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue Forecast by Country (2027-2032) & ($ millions)
Table 93. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Type (2027-2032) & (Units)
Table 94. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Type (2027-2032) & ($ millions)
Table 95. Global Subcutaneous Drug Delivery Equipment Sales Forecast by Application (2027-2032) & (Units)
Table 96. Global Subcutaneous Drug Delivery Equipment Revenue Forecast by Application (2027-2032) & ($ millions)
Table 97. Becton Dickinson Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 98. Becton Dickinson Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 99. Becton Dickinson Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 100. Becton Dickinson Main Business
Table 101. Becton Dickinson Latest Developments
Table 102. Ypsomed Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 103. Ypsomed Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 104. Ypsomed Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 105. Ypsomed Main Business
Table 106. Ypsomed Latest Developments
Table 107. SHL Medical Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 108. SHL Medical Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 109. SHL Medical Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 110. SHL Medical Main Business
Table 111. SHL Medical Latest Developments
Table 112. West Pharmaceutical Services Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 113. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 114. West Pharmaceutical Services Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 115. West Pharmaceutical Services Main Business
Table 116. West Pharmaceutical Services Latest Developments
Table 117. Gerresheimer Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 118. Gerresheimer Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 119. Gerresheimer Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 120. Gerresheimer Main Business
Table 121. Gerresheimer Latest Developments
Table 122. Owen Mumford Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 123. Owen Mumford Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 124. Owen Mumford Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 125. Owen Mumford Main Business
Table 126. Owen Mumford Latest Developments
Table 127. Novo Nordisk Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 128. Novo Nordisk Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 129. Novo Nordisk Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 130. Novo Nordisk Main Business
Table 131. Novo Nordisk Latest Developments
Table 132. Nemera Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 133. Nemera Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 134. Nemera Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 135. Nemera Main Business
Table 136. Nemera Latest Developments
Table 137. Tandem Diabetes Care Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 138. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 139. Tandem Diabetes Care Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 140. Tandem Diabetes Care Main Business
Table 141. Tandem Diabetes Care Latest Developments
Table 142. Enable Injections Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 143. Enable Injections Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 144. Enable Injections Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 145. Enable Injections Main Business
Table 146. Enable Injections Latest Developments
Table 147. Stevanato Group Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 148. Stevanato Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 149. Stevanato Group Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 150. Stevanato Group Main Business
Table 151. Stevanato Group Latest Developments
Table 152. MicroPort Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 153. MicroPort Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 154. MicroPort Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 155. MicroPort Main Business
Table 156. MicroPort Latest Developments
Table 157. Weigao Group Basic Information, Subcutaneous Drug Delivery Equipment Manufacturing Base, Sales Area and Its Competitors
Table 158. Weigao Group Subcutaneous Drug Delivery Equipment Product Portfolios and Specifications
Table 159. Weigao Group Subcutaneous Drug Delivery Equipment Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 160. Weigao Group Main Business
Table 161. Weigao Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Subcutaneous Drug Delivery Equipment
Figure 2. Subcutaneous Drug Delivery Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Drug Delivery Equipment Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Subcutaneous Drug Delivery Equipment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Subcutaneous Drug Delivery Equipment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2025)
Figure 10. Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Syringe
Figure 12. Product Picture of Injection Pen
Figure 13. Product Picture of Implantable Device
Figure 14. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type in 2026
Figure 15. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Manual Injection Device
Figure 17. Product Picture of Spring Driven Device
Figure 18. Product Picture of Motor Driven Device
Figure 19. Product Picture of Gas-Powered Device
Figure 20. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Delivery Mechanism in 2026
Figure 21. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Delivery Mechanism (2021-2026)
Figure 22. Product Picture of Small Molecule Device
Figure 23. Product Picture of Peptide and Protein Device
Figure 24. Product Picture of Nucleic Acid Device
Figure 25. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Drug Type in 2026
Figure 26. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Drug Type (2021-2026)
Figure 27. Product Picture of Disposable Device
Figure 28. Product Picture of Reusable Device
Figure 29. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Reusability in 2026
Figure 30. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Reusability (2021-2026)
Figure 31. Subcutaneous Drug Delivery Equipment Consumed in Disease Treatment
Figure 32. Global Subcutaneous Drug Delivery Equipment Market: Disease Treatment (2021-2026) & (Units)
Figure 33. Subcutaneous Drug Delivery Equipment Consumed in Vaccination
Figure 34. Global Subcutaneous Drug Delivery Equipment Market: Vaccination (2021-2026) & (Units)
Figure 35. Subcutaneous Drug Delivery Equipment Consumed in Aesthetics and Cosmetics
Figure 36. Global Subcutaneous Drug Delivery Equipment Market: Aesthetics and Cosmetics (2021-2026) & (Units)
Figure 37. Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2025)
Figure 38. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application in 2025
Figure 39. Subcutaneous Drug Delivery Equipment Sales by Company in 2025 (Units)
Figure 40. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company in 2025
Figure 41. Subcutaneous Drug Delivery Equipment Revenue by Company in 2025 ($ millions)
Figure 42. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company in 2025
Figure 43. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 46. Americas Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 47. APAC Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 48. APAC Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 49. Europe Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 50. Europe Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 52. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 53. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2025
Figure 54. Americas Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2021-2026)
Figure 55. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 56. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 57. United States Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Region in 2025
Figure 62. APAC Subcutaneous Drug Delivery Equipment Revenue Market Share by Region (2021-2026)
Figure 63. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 64. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 65. China Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 69. India Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2025
Figure 73. Europe Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2021-2026)
Figure 74. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 75. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 76. Germany Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 77. France Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 84. Egypt Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Equipment in 2026
Figure 90. Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
Figure 91. Industry Chain Structure of Subcutaneous Drug Delivery Equipment
Figure 92. Channels of Distribution
Figure 93. Global Subcutaneous Drug Delivery Equipment Sales Market Forecast by Region (2027-2032)
Figure 94. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Subcutaneous Drug Delivery Equipment Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Subcutaneous Drug Delivery Equipment Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Subcutaneous Drug Delivery Equipment
Figure 2. Subcutaneous Drug Delivery Equipment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Subcutaneous Drug Delivery Equipment Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Subcutaneous Drug Delivery Equipment Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Subcutaneous Drug Delivery Equipment Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2025)
Figure 10. Subcutaneous Drug Delivery Equipment Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Syringe
Figure 12. Product Picture of Injection Pen
Figure 13. Product Picture of Implantable Device
Figure 14. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Type in 2026
Figure 15. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of Manual Injection Device
Figure 17. Product Picture of Spring Driven Device
Figure 18. Product Picture of Motor Driven Device
Figure 19. Product Picture of Gas-Powered Device
Figure 20. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Delivery Mechanism in 2026
Figure 21. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Delivery Mechanism (2021-2026)
Figure 22. Product Picture of Small Molecule Device
Figure 23. Product Picture of Peptide and Protein Device
Figure 24. Product Picture of Nucleic Acid Device
Figure 25. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Drug Type in 2026
Figure 26. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Drug Type (2021-2026)
Figure 27. Product Picture of Disposable Device
Figure 28. Product Picture of Reusable Device
Figure 29. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Reusability in 2026
Figure 30. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Reusability (2021-2026)
Figure 31. Subcutaneous Drug Delivery Equipment Consumed in Disease Treatment
Figure 32. Global Subcutaneous Drug Delivery Equipment Market: Disease Treatment (2021-2026) & (Units)
Figure 33. Subcutaneous Drug Delivery Equipment Consumed in Vaccination
Figure 34. Global Subcutaneous Drug Delivery Equipment Market: Vaccination (2021-2026) & (Units)
Figure 35. Subcutaneous Drug Delivery Equipment Consumed in Aesthetics and Cosmetics
Figure 36. Global Subcutaneous Drug Delivery Equipment Market: Aesthetics and Cosmetics (2021-2026) & (Units)
Figure 37. Global Subcutaneous Drug Delivery Equipment Sale Market Share by Application (2025)
Figure 38. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Application in 2025
Figure 39. Subcutaneous Drug Delivery Equipment Sales by Company in 2025 (Units)
Figure 40. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Company in 2025
Figure 41. Subcutaneous Drug Delivery Equipment Revenue by Company in 2025 ($ millions)
Figure 42. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Company in 2025
Figure 43. Global Subcutaneous Drug Delivery Equipment Sales Market Share by Geographic Region (2021-2026)
Figure 44. Global Subcutaneous Drug Delivery Equipment Revenue Market Share by Geographic Region in 2025
Figure 45. Americas Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 46. Americas Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 47. APAC Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 48. APAC Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 49. Europe Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 50. Europe Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 51. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales 2021-2026 (Units)
Figure 52. Middle East & Africa Subcutaneous Drug Delivery Equipment Revenue 2021-2026 ($ millions)
Figure 53. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2025
Figure 54. Americas Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2021-2026)
Figure 55. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 56. Americas Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 57. United States Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 58. Canada Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 59. Mexico Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 60. Brazil Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 61. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Region in 2025
Figure 62. APAC Subcutaneous Drug Delivery Equipment Revenue Market Share by Region (2021-2026)
Figure 63. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 64. APAC Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 65. China Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 66. Japan Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 67. South Korea Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 68. Southeast Asia Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 69. India Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 70. Australia Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 71. China Taiwan Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 72. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Country in 2025
Figure 73. Europe Subcutaneous Drug Delivery Equipment Revenue Market Share by Country (2021-2026)
Figure 74. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 75. Europe Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 76. Germany Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 77. France Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 78. UK Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 79. Italy Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 80. Russia Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 81. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Country (2021-2026)
Figure 82. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Type (2021-2026)
Figure 83. Middle East & Africa Subcutaneous Drug Delivery Equipment Sales Market Share by Application (2021-2026)
Figure 84. Egypt Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 85. South Africa Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 86. Israel Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 87. Turkey Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 88. GCC Countries Subcutaneous Drug Delivery Equipment Revenue Growth 2021-2026 ($ millions)
Figure 89. Manufacturing Cost Structure Analysis of Subcutaneous Drug Delivery Equipment in 2026
Figure 90. Manufacturing Process Analysis of Subcutaneous Drug Delivery Equipment
Figure 91. Industry Chain Structure of Subcutaneous Drug Delivery Equipment
Figure 92. Channels of Distribution
Figure 93. Global Subcutaneous Drug Delivery Equipment Sales Market Forecast by Region (2027-2032)
Figure 94. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Region (2027-2032)
Figure 95. Global Subcutaneous Drug Delivery Equipment Sales Market Share Forecast by Type (2027-2032)
Figure 96. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Type (2027-2032)
Figure 97. Global Subcutaneous Drug Delivery Equipment Sales Market Share Forecast by Application (2027-2032)
Figure 98. Global Subcutaneous Drug Delivery Equipment Revenue Market Share Forecast by Application (2027-2032)
